{"podcast":{"title":"California News Today | 2 Min News | The Daily News Now!","slug":"california-news-today-2-min-news-the-daily-news-now-7610473","podcast_index_feed_id":7610473,"rss_url":"https://feeds.fastcast.ai/california-news-today-2-min-news-the-daily-news-now.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/california-news-today-2-min-news-the-daily-news-now.jpg","author":"The Daily News Now!","episode_count":590,"summary":"Hosted by Corey with the Story, California News Today delivers fast, focused daily updates on the stories shaping California—from statewide politics and business to culture, sports, and major local developments. Designed for quick, on-the-go listening, each episode brings you up to speed in minutes. Produced by AI for speed, consistency, and global scale, the show is part of The Daily News Now network—bringing local and regional news to every market in the world and keeping communities connected. California News Today is your daily snapshot of what’s happening across the state. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-06-17T22:20:05.463017+00:00","page_url":"https://stenobird.com/podcast/california-news-today-2-min-news-the-daily-news-now-7610473"},"episode":{"title":"FDA Approves New Alzheimer's Drug, Lecanemab","slug":"fda-approves-new-alzheimer-s-drug-lecanemab","published_at":"2026-05-22T19:32:15+00:00","page_url":"https://stenobird.com/podcast/california-news-today-2-min-news-the-daily-news-now-7610473/fda-approves-new-alzheimer-s-drug-lecanemab","show_page_url":"https://stenobird.com/podcast/california-news-today-2-min-news-the-daily-news-now-7610473","url":"https://api.fastcast.ai/audio/2f8bffb2-9ad3-4930-b859-69100e2dbf61.mp3","audio_url":"https://api.fastcast.ai/audio/2f8bffb2-9ad3-4930-b859-69100e2dbf61.mp3","summary":"The FDA has approved Lecanemab, a new drug for early-stage Alzheimers, marking a significant step in the fight against the disease. This medication targets and clears amyloid plaques, which contribute to cognitive decline. After clinical trials showed it could slow progression, the FDA approved it, offering hope to patients and families. However, experts caution that its effectiveness and safety are still being monitored, and patients should discuss potential benefits and risks with their healthcare providers. Further research is needed to understand its long-term impact, and the FDA will continue to monitor its performance and side effects. This development underscores the ongoing effort in medical science to find effective treatments for complex diseases. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/77a02edaee2257e7","meta_description":"The FDA has approved Lecanemab, a new drug for early-stage Alzheimers, marking a significant step in the fight against the disease. This medication target…","key_points":[],"chapters":[],"topics":[],"duration_seconds":121,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/california-news-today-2-min-news-the-daily-news-now-7610473/episodes/fda-approves-new-alzheimer-s-drug-lecanemab/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/california-news-today-2-min-news-the-daily-news-now-7610473/fda-approves-new-alzheimer-s-drug-lecanemab.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}